Hu C - Search Results

1

Personalized Risk Prediction in Clinical Oncology Research: Applications and Practical Issues Using Survival Trees and Random Forests.

Hu C, Steingrimsson JA. Hu C, et al. J Biopharm Stat. 2018;28(2):333-349. doi: 10.1080/10543406.2017.1377730. Epub 2017 Oct 19. J Biopharm Stat. 2018. PMID: 29048993 Free PMC article.

2

Covariate adjustment using propensity scores for dependent censoring problems in the accelerated failure time model.

Cho Y, Hu C, Ghosh D. Cho Y, et al. Among authors: hu c. Stat Med. 2018 Feb 10;37(3):390-404. doi: 10.1002/sim.7513. Epub 2017 Oct 10. Stat Med. 2018. PMID: 29023972 Free PMC article.

3

Comparison of Duration of Response vs Conventional Response Rates and Progression-Free Survival as Efficacy End Points in Simulated Immuno-oncology Clinical Trials.

Hu C, Wang M, Wu C, Zhou H, Chen C, Diede S. Hu C, et al. JAMA Netw Open. 2021 May 3;4(5):e218175. doi: 10.1001/jamanetworkopen.2021.8175. JAMA Netw Open. 2021. PMID: 34047794 Free PMC article.

4

Simultaneous hypothesis testing for multiple competing risks in comparative clinical trials.

Wen J, Wang MC, Hu C. Wen J, et al. Among authors: hu c. Stat Med. 2023 Jun 30;42(14):2394-2408. doi: 10.1002/sim.9728. Epub 2023 Apr 10. Stat Med. 2023. PMID: 37035880 Free PMC article.

5

Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?

Wang M, Chen C, Jemielita T, Anderson J, Li XN, Hu C, Kang SP, Ibrahim N, Ebbinghaus S. Wang M, et al. Among authors: hu c. J Immunother Cancer. 2019 Feb 8;7(1):39. doi: 10.1186/s40425-019-0513-4. J Immunother Cancer. 2019. PMID: 30736858 Free PMC article. Clinical Trial.

6

Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact.

Hazell SZ, Mai N, Fu W, Hu C, Friedes C, Negron A, Voong KR, Feliciano JL, Han P, Myers S, McNutt TR, Hales RK. Hazell SZ, et al. Among authors: hu c. BMC Cancer. 2020 Apr 19;20(1):334. doi: 10.1186/s12885-020-06843-z. BMC Cancer. 2020. PMID: 32306924 Free PMC article.

7

Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review.

Zhu J, Yang Y, Tao J, Wang SL, Chen B, Dai JR, Hu C, Qi SN, Li YX. Zhu J, et al. Among authors: hu c. Leukemia. 2020 Oct;34(10):2576-2591. doi: 10.1038/s41375-020-0963-1. Epub 2020 Jul 10. Leukemia. 2020. PMID: 32651542 Free PMC article.

8

Biomarker-Driven Oncology Clinical Trials: Key Design Elements, Types, Features, and Practical Considerations.

Hu C, Dignam JJ. Hu C, et al. JCO Precis Oncol. 2019 Oct 24;3:PO.19.00086. doi: 10.1200/PO.19.00086. eCollection 2019. JCO Precis Oncol. 2019. PMID: 32923854 Free PMC article. Review.

9

Are restricted mean survival time methods especially useful for noninferiority trials?

Freidlin B, Hu C, Korn EL. Freidlin B, et al. Among authors: hu c. Clin Trials. 2021 Apr;18(2):188-196. doi: 10.1177/1740774520976576. Epub 2021 Feb 24. Clin Trials. 2021. PMID: 33626896 Free PMC article.

10

External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases.

Elledge CR, LaVigne AW, Fiksel J, Wright JL, McNutt T, Kleinberg LR, Hu C, Smith TJ, Zeger S, DeWeese TL, Alcorn SR. Elledge CR, et al. Among authors: hu c. JCO Clin Cancer Inform. 2021 Mar;5:304-314. doi: 10.1200/CCI.20.00128. JCO Clin Cancer Inform. 2021. PMID: 33760638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,446 results

Search Page

Filters